RxDoctor Payments Data

Jennifer Jones, MD

Family Medicine · Gainesville, FLNPI 1245467158

Payments from drug & device makers

$19,551in general payments, 2019–2025

Across 54 payments — averaging $362.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$14K
  • Roche Diabetes Care, Inc.$5K
  • Novo Nordisk$224
  • Amgen$36
  • Exact Sciences$34
  • Johnson & Johnson$23
  • plus $95 from 6 others

What the payments were for

  • Consulting fees$8,26242%
  • Speaking & faculty fees$6,87035%
  • Travel & lodging$3,50718%
  • Food & beverage$9115%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,551 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$184,340
Medicare patients
297
Services billed
3,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$107,194
JardianceEmpagliflozin72$78,970
EliquisApixaban47$50,295
MounjaroTirzepatide38$43,323
Nurtec OdtRimegepant Sulfate12$22,690
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$21,607
JanuviaSitagliptin Phosphate17$20,034
FarxigaDapagliflozin Propanediol13$17,800
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$13,046
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,739
Spiriva RespimatTiotropium Bromide12$6,300
Atorvastatin Calcium612$5,918
Combivent RespimatIpratropium/Albuterol Sulfate12$5,741
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,606
Lansoprazole16$5,095

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$224$107,19482 claims
PfizerEliquis, Nurtec Odt$17$72,98559 claims
Lilly USA, LLCMounjaro$13$43,32338 claims
GSKTrelegy Ellipta, Anoro Ellipta$13$18,34523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →